Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
PH
Phetuvov
Community Contributor
Cardiac marker could be a hit
In 5 years, the company should still be thriving, entering new markets and expanding in existing ones. Positive passage of the third stage of testing of a new cardiac marker could help.
View narrativezł204.19
FV
9.5% overvalued intrinsic discount8.49%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
3 months ago author updated this narrative